Figure 1

DC-based Immunotherapy for T1D

CIT researchers demonstrate that DC therapy leads to long-lasting immunomodulatory effects in an antigen-dependent and antigen-independent manner.

Fig 5

A New Nanoscale Technology

Proteomic profiling of single human pancreatic islet sections using a new nanoscale technology called nanoPOTS

Processed EEG Monitoring Devices for Assessment of Depth of Anesthesia

CIT members discuss the advantages and limitations of this technology in the clinical setting as a tool in our repertoire used for optimizing individualized patient care.

Metformin attenuates the Type I Interferon response in human peripheral blood leukocytes

CIT researchers provide evidence that the therapeutic potential of metformin in lupus may be multifaceted, including the modulation of type I IFN stimulated genes, as well as STAT3 signaling.

CIT Members Make News

UF Diabetes Institute researchers discover way to expand potent regulatory cells

The Journal of Pain

CIT member, Dr. Shannon Wallet, finds peripheral mechanisms involved in the response to pain may change with age.

Prev Next

Recent News

CIT Members Make News

Apr 21st, 2017

UF Diabetes Institute researchers discover way to expand potent regulatory cells

The Journal of Pain

Apr 18th, 2017

CIT member, Dr. Shannon Wallet, finds peripheral mechanisms involved in the response to pain may change with age.